Pharma’s Gold Rush for Obesity Drugs

Pharma’s Gold Rush for Obesity Drugs

Pharma’s Gold Rush for Obesity Drugs Published May 2024 A new class of weight loss drugs known as GLP-1 has led to Wall Street’s soaring excitement for pharmaceutical companies’ blockbuster opportunity to capitalize on the obesity problem in the U.S. and to a lesser extent in other countries. According to the Centers for Disease Control Read More